ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances
About this episode
This episode explores advances in Cardiovascular-Kidney-Metabolic syndrome and related treatments.
ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).
More episodes of Journal of the American Society of Nephrology (JASN)
- Barriers to Kidney Transplantation in the United States
- ASN Kidney Translation Series: ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome
- APOL1 at the Plasma Membrane and Cytotoxicity
- Temporal, Cell-Specific Angiopoietin-2 in CKD
- Cardiovascular Effects of GLP-1 RA in Kidney Failure
- ASN Kidney Translation Series: Artificial Intelligence in Nephrology
Explore listener stats, chart rankings, contacts and more on the Journal of the American Society of Nephrology (JASN) podcast page.